
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 143 | 505.80 | 506.50 | 3 |
| 4 | 505.70 | 506.55 | 5 |
| 5 | 505.65 | 506.70 | 42 |
| 12 | 505.60 | 506.80 | 11 |
| 96 | 505.55 | 506.85 | 11 |
| 17332 | Total | Total | 12285 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 143 | 505.80 | 506.50 | 3 |
| 4 | 505.70 | 506.55 | 5 |
| 5 | 505.65 | 506.70 | 42 |
| 12 | 505.60 | 506.80 | 11 |
| 96 | 505.55 | 506.85 | 11 |
| 17332 | Total | Total | 12285 |
| Open | 507.80 |
| Previous Close | 510.05 |
| Volume | 69,446.00 |
| Value (Lacs) | 352.13 |
| VWAP | 506.31 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 12,173 |
| High | 509.95 |
| Low | 504.85 |
| UC Limit | 612.05 |
| LC Limit | 408.05 |
| 52 Week High | 694.40 |
| 52 Week Low | 499.00 |
| Face Value | 2.00 |
| All Time High | 736.30 |
| All Time Low | 470.10 |
| 20D Avg Volume | 573,542 |
| 20D Avg Delivery(%) | 24.23 |
| Book Value Per Share | 98.31 |
| Dividend Yield | 0.39 |
| TTM EPS See historical trend | 18.57 (+40.22% YoY) |
| TTM PE See historical trend | 27.30 |
| P/B See historical trend | 5.16 (Low P/B) |
| Sector PE | 47.53 |
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Indegene Consolidated September 2025 Net Sales at Rs 804.20 crore, up 17.09% Y-o-Y Nov 03 2025 10:00 AM
Stocks to Watch Today: Reliance, BEL, V2 Retail, MTAR, Associated Alcohols, Swiggy, Bandhan Bank, Manappuram, TD Power, United Spirits, Welspun Corp, Lodha in focus on 31 October Oct 31 2025 03:35 AM
Health adtech player Indegene rides Trump pharma shakeup with AI-driven outreach Oct 08 2025 12:58 PM
Indegene acquires BioPharm to boost AI-powered pharma marketing Oct 01 2025 10:26 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 16849018 | Price 591.02 | % Traded 7.03 |
| Qty 7626384 | Price 591.84 | % Traded 3.18 |
| Qty 3387325 | Price 591.26 | % Traded 1.41 |
| Qty 3348661 | Price 592.9 | % Traded 1.40 |
| Qty 2168000 | Price 591 | % Traded 0.90 |
| Qty 1879775 | Price 591 | % Traded 0.78 |
| Qty 1827856 | Price 591 | % Traded 0.76 |
| Qty 1827855 | Price 591 | % Traded 0.76 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Indegene | 506.45 | -0.71 | 12,158.81 | 58.15 | 6.86 | 9.60 | -20.90 | 181 | 1,093 | 0.00 |
| Poly Medicure | 1,990.60 | 6.06 | 20,176.62 | 55.74 | 7.79 | 12.24 | -22.91 | 333 | 1,669 | 0.06 |
| AARTIPHARM | 693.25 | -0.11 | 6,284.12 | 26.21 | 3.38 | 13.68 | 6.10 | 272 | 2,115 | 0.20 |
| Prevest Denpro | 455.00 | -1.13 | 546.14 | 27.43 | 5.17 | 17.23 | -15.74 | 18 | 63 | 0.00 |
| Hemant Surgical | 266.60 | -3.07 | 347.60 | 33.58 | 5.30 | 12.91 | 95.31 | 8 | 106 | 0.49 |